Search
for
Sort by
Research 871–900 of 1000+
- Successful Management of Trichotillomania with an Integrated Approach: A Case Study
- Baricitinib Provides Holistic Improvement in Scalp, Eyebrow and Eyelash Regrowth in Adolescents With Severe Alopecia Areata
- Alopecia areata: An update
- NON-PSORALEN TREATMENT OF VITILIGO. PART II. LESS COMMONLY USED AND EXPERIMENTAL THERAPIES
- Pregnancy and the Skin
- Short anagen syndrome: Case series and literature review
- Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
- Interplay between EDA-EDAR and WNT signalling pathways in the development of skin appendages in hypohidrotic ectodermal dysplasia
- Caring for women with polycystic ovary syndrome
- Homoeopathic management of alopecia areata barbae with Kali carbonicum: A case report
- Alopecia Areata in a Patient Undergoing Treatment for Secondary Syphilis: A Diagnostic Challenge
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Obesity and the Polycystic Ovary Syndrome
- Alopecia Areata Update
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- 11 Treatment of hirsutism and acne with cyproterone acetate
- Compounding as a Current Therapeutic Option in Dermatology
- One of These Things Is Not Like the Others: The Idea of Precedence in Health Technology Assessment and Coverage Decisions
- The Rotterdam Study: 2016 objectives and design update
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- 93 Approach to Managing Recalcitrant Alopecia Areata With Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Finasteride in Young Men: Effects on Semen and Hormones?
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Alopecia Universalis: Never Give Up?
- Trimethoprim-Induced Aseptic Meningitis
- Baricitinib for the Treatment of Alopecia Areata
- Trimethoprim-induced aseptic meningitis